Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe SARS-CoV2 Pneumonia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT04884490
What this trial is testing

The Role of High Dose Co-trimoxazole in Severe Covid-19 Patients

Who this might be right for
COVID-19 Pneumonia
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh 94
Not applicableStudy completedNCT04667923
What this trial is testing

Noninvasive Ventilation in Moderate-to-severe COVID-19-associated Acute Respiratory Distress-syndrome

Who this might be right for
Covid19ARDS
I.M. Sechenov First Moscow State Medical University 80
Not applicableStudy completedNCT04733625
What this trial is testing

The Effect of Vitamin D Therapy on Morbidity and Moratlity in Patients With SARS-CoV 2 Infection

Who this might be right for
Covid19SARS-CoV Infection
Kasr El Aini Hospital 56
Testing effectiveness (Phase 2)Active Not RecruitingNCT04488081
What this trial is testing

I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients

Who this might be right for
COVID-19
QuantumLeap Healthcare Collaborative 1,500
Very early researchWithdrawnNCT04528771
What this trial is testing

S-Nitrosylation Therapy of COVID-19

Who this might be right for
SARS-CoV2 InfectionCovid19
James Reynolds
Testing effectiveness (Phase 2)Study completedNCT05567952
What this trial is testing

Learn About a Repeat 5-Day Treatment With the Study Medicines (Called Nirmatrelvir/Ritonavir) in People 12 Years Old or Older With Return of COVID-19 Symptoms and SARS-CoV-2 Positivity After Finishing Treatment With Nirmatrelvir/Ritonavir

Who this might be right for
COVID-19
Pfizer 436
Not applicableWithdrawnNCT04456426
What this trial is testing

Characteristics of Patients With COVID-19 in Meta State, Colombia

Who this might be right for
COVIDSARS-CoV 2SARS Pneumonia+2 more
Hospital Departamental de Villavicencio
Not applicableStudy completedNCT05894499
What this trial is testing

Post-Marketing Safety Study in Japan of Shock and Anaphylaxis After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA-1273 COVID-19 Vaccine in Persons in at High Risk of Severe COVID-19

Who this might be right for
SARS-CoV-2
ModernaTX, Inc. 13,309
Testing effectiveness (Phase 2)Study completedNCT04561063
What this trial is testing

COVID-19 Prophylaxis South Africa (COVER HCW)

Who this might be right for
Covid19SARS-CoV Infection
University of Witwatersrand, South Africa 1,950
Not applicableStudy completedNCT05439044
What this trial is testing

A Real-World Study of Anti-SARS-CoV-2 Monoclonal Antibodies in Prophylaxis and Curative of Covid-19 (COVIMAB)

Who this might be right for
Immunocompromised Patients
Assistance Publique - Hôpitaux de Paris 4,235
Testing effectiveness (Phase 2)Study completedNCT04312009
What this trial is testing

Losartan for Patients With COVID-19 Requiring Hospitalization

Who this might be right for
Corona Virus InfectionAcute Respiratory Distress SyndromeSARS-CoV Infection
University of Minnesota 205
Not applicableEnded earlyNCT04361344
What this trial is testing

Neurodegeneration Markers and Neurological Course in Severe Covid-19 Infection

Who this might be right for
COVID-19 InfectionEncephalitis
Centre Hospitalier de PAU 2
Testing effectiveness (Phase 2)Study completedNCT04524507
What this trial is testing

Coronavirus Disease 2019 (COVID-19) Antibody Plasma Research Study in Hospitalized Patients

Who this might be right for
COVID-19
University of North Carolina, Chapel Hill 56
Testing effectiveness (Phase 2)Study completedNCT04363736
What this trial is testing

Investigate Intravenous Tocilizumab in Participants With Moderate to Severe COVID-19 Pneumonia

Who this might be right for
COVID-19 Pneumonia
Hoffmann-La Roche 97
Large-scale testing (Phase 3)Study completedNCT07069309
What this trial is testing

Learn About COVID-19 RNA-Based Variant-Adapted Vaccine Candidate(s) Against SARS-CoV-2 in Participants Ages 12 Through 64 Years Considered at Higher Risk of Severe COVID-19, and Participants Ages ≥65 Years

Who this might be right for
COVID-19SARS-COV-2 Infection
BioNTech SE 774
Testing effectiveness (Phase 2)WithdrawnNCT05035238
What this trial is testing

Evaluation of the Efficacy, Safety and Immunogenicity of Inactivated COVID 19 Vaccine(TURKOVAC) in Healthy Population of 18 and 64 Years of Age (Both Inclusive):a Randomized, Double-blind, Phase IIb Clinical Trial

Who this might be right for
Covid19
Health Institutes of Turkey
Testing effectiveness (Phase 2)UnknownNCT04268537
What this trial is testing

Immunoregulatory Therapy for 2019-nCoV

Who this might be right for
2019 nCoV, PD-1
Southeast University, China 120
Early research (Phase 1)UnknownNCT04428073
What this trial is testing

Therapeutic Vaccine Trial of COVID-19 for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection

Who this might be right for
COVID
GeneCure Biotechnologies 32
Not applicableStudy completedNCT04376840
What this trial is testing

Prevalence of Long-term Respiratory Complications of Severe SARS-CoV-2 Pneumonia - COVID-19

Who this might be right for
Severe SARS-CoV2 Pneumonia
CHU de Reims 150
Large-scale testing (Phase 3)Study completedNCT04308668
What this trial is testing

Post-exposure Prophylaxis / Preemptive Therapy for SARS-Coronavirus-2

Who this might be right for
Corona Virus InfectionAcute Respiratory Distress SyndromeSARS-CoV Infection+2 more
University of Minnesota 1,312
Next Page